Platform Technology for
       Minimally Invasive Medical Devices


The PathFormer device is featured in the Podiatry Today under surgical pearls. The article authored by Andreas Boker, MD and Jesse Burks, DPM reviews the use of PathFormer in treating nail conditions such as onychomycosis and black toe (subungual hematoma).
Surgical Pearls: Can A New Nail Trephination Device Help Treat Nail Conditions?
Podiatry Today - ISSN: 1045-7860 - Volume 20 - Issue 11 - November 2007 - Pages: 34 - 36

A phase I trial was conducted at the Brigham and Women's Hospital, Boston, MA to evaluate the efficacy of topical treatment of onychomycosis via microconduits created by the PathFormer. Treatment of subungual onychomycosis with topical terbinafine delivered to the nail bed via transungual microconduits shows promise in this small blinded pilot study with 71% of the subjects showing improvement in clinical assessment compared to 28% in the placebo group. The results were presented at the 65th Annual Meeting of the American Academy of Dermatology, Washington D.C., Feb 2-6, 2007.
Topical treatment of onychomycosis via microconduits (pdf)

The use of PathFormer to relieve subungual hematoma is published in The American Journal of Emergency Medicine.
PathFormer and subungual hematoma relief (pdf)

A pilot study was conducted at the Brigham and Women's Hospital, Boston, MA to test the safety and tolerance of creating toenail microconduits using the PathFormer. All subjects felt no or momentary pin-prick sensation. The results were reported in the journal Dermatologic Surgery.
PathFormer Sensation Study (pdf)